Shine-On BioMedical Co.,Ltd. (6926.TWO)

65.00 +0.20 (+0.31%) At close: 10:56AM CST

Shine-On BioMedical Co.,Ltd.

No. 633, Taiwan Avenue
5F-6 Section 2 Xitun District
Taichung 407
Taiwan
886 4 2327 2888
https://www.shineon-bio.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 19

Description

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as SOA101, a dual immune checkpoint inhibitor; and SOA201, a trispecific antibody composed of dual immune cells, as well as exosome anti-cancer drugs, that includes SOB101. The company was founded in 2021 and is based in Taichung, Taiwan.

Corporate governance

Shine-On BioMedical Co.,Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.